Hemostatic changes during extracorporeal membrane oxygenation:

Veno-venous extracorporeal membrane oxygenation (ECMO) is a technique utilized to support patients suffering from respiratory failure. Historically, ECMO has been used as a last resort life-saving procedure by a restricted group of highly specialized centers of care. Recently, interest in ECMO has risen. Technology advancements have made ECMO safer (1). The CESAR trial showed that Acute Respiratory Distress Syndrome (ARDS) patients might have better outcomes if treated with ECMO rather than conventional strategies (2). The H1N1 experience demonstrated the feasibility of implementation of ECMO even in centers with limited experience (3).